List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 49 studies with search of:   Ecuador
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed A Pilot Study of Neurocysticercosis Treatment
Condition: Neurocysticercosis
Interventions: Drug: albendazole;   Other: placebo
2 Recruiting Study Of Celecoxib Or Diclofenac And Omeprazole For Gastrointestinal (GI) Safety In High GI Risk Patients With Arthritis
Conditions: Osteoarthritis;   Arthritis, Rheumatoid
Interventions: Drug: Celecoxib;   Drug: Diclofenac + Omeprazole
3 Active, not recruiting Anastrozole Plus Lonafarnib (SCH 66336) or Plus Placebo for the Treatment of Advanced Breast Cancer (Study P03480AM5)
Condition: Breast Cancer
Interventions: Drug: Lonafarnib plus Anastrozole;   Drug: Placebo plus Anastrozole
4 Completed Pediatric ADVAIR DISKUS Versus Oral Montelukast Chewable Tablets
Condition: Asthma
Interventions: Drug: montelukast (5mg QD);   Drug: Salmeterol/Fluticasone propionate Inhalation Powder (50/100mcg BID)
5 Active, not recruiting BBR 2778 for Relapsed, Aggressive Non-Hodgkin's Lymphoma (NHL)
Condition: Lymphoma, Non-Hodgkin
Interventions: Drug: pixantrone, cyclophosphamide, vincristine, rituximab, prednisone;   Drug: Vinorelbine, Oxalplatin, Ifosfasmide, Etoposide, Mitoxatrone, Gemcitabine or Rituximab
6 Completed Study of LED Phototherapy for Musculoligamentous Lesions
Conditions: Tendinopathy;   Sprains and Strains;   Muscle Spasm;   Epicondylitis;   Fasciitis
Intervention: Device: Red and near infrared LED phototherapy device
7 Completed Efficacy, Safety and Tolerability of Once-Daily (o.d.) Indacaterol in Chronic Obstructive Pulmonary Disease (COPD) Using Formoterol Twice Daily (b.i.d.) as Active Control
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Indacaterol (300 µg o.d.);   Drug: Indacaterol (600 µg o.d.);   Drug: formoterol 12ug bid;   Drug: placebo
8 Recruiting A Study of Avastin (Bevacizumab) in Combination With MabThera (Rituximab) and CHOP Chemotherapy in Patients With Diffuse Large B-Cell Lymphoma.
Condition: Lymphoma, B-Cell
Interventions: Drug: bevacizumab [Avastin];   Drug: R-CHOP;   Drug: Placebo
9 Recruiting A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Subjects With Metastatic Breast Cancer Receiving Standard Chemotherapy
Conditions: Neoplasm Metastasis;   Breast Cancer
Intervention: Drug: epoetin alfa
10 Active, not recruiting A Non-Comparative Study to Assess the Safety of MabThera (Rituximab) in Patients With Rheumatoid Arthritis.
Condition: Rheumatoid Arthritis
Interventions: Drug: rituximab [MabThera/Rituxan];   Drug: Methotrexate
11 Active, not recruiting A Study of Avastin (Bevacizumab) in Combination With Platinum-Containing Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer.
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: bevacizumab [Avastin];   Drug: Platinum-based chemotherapy
12 Active, not recruiting Vicriviroc in HIV-Treatment Experienced Subjects (Study P04405AM3)
Conditions: HIV Infections;   Acquired Immunodeficiency Syndrome
Interventions: Drug: Vicriviroc maleate 30 mg;   Drug: Placebo tablet
13 Completed Treatment of Incomplete Abortion With 600 Mcg Oral Misoprostol Compared to Standard Surgical Treatment
Condition: Incomplete Abortion
Interventions: Drug: 600 mcg misoprostol;   Procedure: Surgical treatment
14 Active, not recruiting MAXIMA Study: A Study of Maintenance Therapy With MabThera (Rituximab) in Patients With Non-Hodgkin's Lymphoma.
Condition: Non-Hodgkin's Lymphoma
Intervention: Drug: rituximab [MabThera/Rituxan]
15 Recruiting A Study to Evaluate the Safety, Tolerability, and Activity of Lonafarnib and Docetaxel (Study P04467AM1)
Conditions: Prostate Cancer;   Breast Cancer;   Ovarian Cancer;   Lung Cancer;   Gastric Cancer
Intervention: Drug: Docetaxel plus lonafarnib
16 Not yet recruiting A Study to Assess the Effect of Tocilizumab Plus Methotrexate on Safety and Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis.
Condition: Rheumatoid Arthritis
Interventions: Drug: tocilizumab;   Drug: methotrexate
17 Recruiting Traditional Acupuncture and Myofascial Trigger Point Dry Needling and Acupressure for Chronic Low Back Pain
Condition: Low Back Pain
Interventions: Procedure: Traditional needle acupuncture;   Procedure: Myofascial trigger point dry needling;   Procedure: Myofascial trigger point acupressure
18 Recruiting Treatment Use Study With Sunitinib (SU011248) For Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma
Condition: Carcinoma, Renal Cell
Intervention: Drug: sunitinib malate
19 Completed Olmesartan Alone or in Combination With Hydrochlorothiazide in Subjects With Mild to Moderate Essential Hypertension
Condition: Essential Hypertension
Intervention: Drug: olmesartan alone or in combination with hydrochlorothiazide
20 Recruiting Efficacy And Safety Of Parecoxib 40mg vs. Ketoprofen 100mg In The Management Of Acute Renal Colic
Condition: Pain
Interventions: Drug: Ketoprofen 100mg;   Drug: Parecoxib 40mg

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services